HARINI DOPPALAPUDI: Open Payments
NPI 1316926389 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 48 payments from 14 companies in 2025. Trend: 2023 $300 · 2024 $668 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 8 | $178 |
| Novo Nordisk Inc | 10 | $158 |
| Novartis Pharmaceuticals Corporation | 6 | $144 |
| Amgen Inc. | 6 | $111 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Exact Sciences Corporation | 3 | $56 |
| Abbott Laboratories | 2 | $56 |
| Lilly USA, LLC | 3 | $52 |
| Viatris Specialty LLC | 2 | $38 |
| Corcept Therapeutics | 1 | $26 |
Products named: Dexcom G6 Transmitter, LEQVIO, Ozempic, KRYSTEXXA, Cologuard Collection Kit, ENSITE, MOUNJARO, Wegovy.
Industry payments across AL — which companies pay providers there.
